News from bionity.com

Antibiotics: Same Target, Different Effects

Even if they attack the same target in the bacterial cell, the cellular response to different antibiotics can vary. There is an urgent need for new antimicrobial strategies to keep pathogens in check. This applies specifically to Gram-negative bacteria, which are protected from antibiotic interventi...

more…

Machine learning classifier accelerates the development of cellular immunotherapies

Making a personalised T cell therapy for cancer patients currently takes at least six months; scientists at the German Cancer Research Center (DKFZ) and the University Medical Center Mannheim have shown that the laborious first step of identifying tumor-reactive T cell receptors for patients can be ...

more…

Sustainable plastics from agricultural waste

In our rapidly industrialized world, the quest for sustainable materials has never been more urgent. Plastics, ubiquitous in daily life, pose significant environmental challenges, primarily due to their fossil fuel origins and problematic disposal. Now, a study led by Jeremy Luterbacher's team at EP...

more…

Possible tumour marker found for the development of hepatocellular carcinoma

A research team at the MHH is comparing changes in natural killer cells of the innate immune defence system in chronic hepatitis C sufferers as a risk factor for the later development of hepatocellular carcinoma (HCC). Hepatocellular carcinoma (HCC) is a malignant liver tumour that develops from deg...

more…

New starting point discovered in the fight against Pseudomonas aeruginosa

Pseudomonas aeruginosa is an important opportunistic pathogen responsible for life-threatening infections that are associated with high rates of morbidity and mortality. Researchers from TWINCORE, the Centre for Experimental and Clinical Infection Research in Hannover, and the Helmholtz Centre for I...

more…

Bayer and Aignostics to collaborate on next generation precision oncology

Bayer and Aignostics GmbH announced a strategic collaboration on several artificial intelligence (AI)-powered approaches with applications in precision oncology drug research and development. Aignostics is a spin-off from one of the world’s leading hospitals, Charité-Universitätsmedizin Berlin, and ...

more…

Tubulis closes upsized €128 million Series B2

Tubulis announced the successful completion of an upsized and oversubscribed €128 million ($138.8 million) Series B2 financing. The round was co-led by EQT Life Sciences and Nextech Invest Ltd, on behalf of one or more funds managed by it, with participation from new US-based funds, Frazier Life Sci...

more…

Researchers “film” the activation of an important receptor

An international team of researchers has succeeded in “filming” the activation of an important receptor. They froze the involved molecules at different points in time and photographed them under the electron microscope. They were then able to place these still images in sequence. This sequence shows...

more…

Protection from an unexpected source

Contrary to common belief, not all viruses are harmful to their hosts. Sometimes viruses can even protect their hosts from infection by other viruses. Scientists at the Max-Planck-Institute for Medical Research in Heidelberg and their collaborators have now demonstrated that this is the case for so-...

more…

Interaction between metabolic health and healthy aging supported

New findings on the role of RNA Polymerase I in longevity and metabolic health - excessive protein synthesis shortens lifespan - connection between energy metabolism and cancer risk. Ribosomes, the "translation factories" of the cell, are cellular organelles that play a central role in protein synth...

more…